DoubleVerify Q1 2026 Earnings EPS Misses Estimates Stock Declines TBN Q1 2026 Earnings EPS Miss Reflects Exploration Costs and No Revenue Generation Skye Bioscience Q1 2026 Earnings Wider Loss Than Expected as DevelopmentStage Biotech Continues Cash Burn Lexeo Therapeutics Q1 2026 Earnings EPS Beat on Lower Operating Costs GETY Q1 2026 Earnings EPS Misses by Wide Margin Stock Gains on Strategic Momentum Ziff Davis Q1 2026 Earnings EPS Misses Estimates Stock Rises 475